Impact of the eSalut Program in Hospital-at-Home (HOMeSALUT)

The objective of the study is to evaluate the impact caused by the use of the e-Salut Metro Nord App on the home hospitalization care process compared to the conventional model of care. A randomized clinical trial will be conducted with two groups: control group (patients using the conventional care model) and experimental group (patients using the app). The study population includes patients admitted to the Home Hospitalization Unit (HAD) of the Hospital Universitari Germans Trias i Pujol who agree to participate between January 2024 and April 2025. The independent variable is the use of the App. The dependent/outcome variables include: generated alerts, number of patient-initiated phone calls to professionals, App users who complete questionnaires, detected complications, unplanned in-person visits in HAD, unplanned phone visits in HAD, scheduled in-person nursing visits, scheduled medical visits, time elapsed between an alert and the professional's response, time for management and resolution of complications, unplanned visits generated by alerts, number of readmissions, patient/caregiver satisfaction, sex, age, functional assessment (Barthel Index), cognitive impairment assessment (Pfeiffer Test), anxiety and depression scales (HADS), patient activation measure (PAM-13), empowerment measure (CEPEC-47), therapeutic adherence test (ARMS-e), and health literacy (HLS-EU-Q16).

NCT Number	NCT07386275
Lead Sponsor	Germans Trias i Pujol Hospital
Conditions	Hospital at Home, Patients Admitted to Hospital at Home Unit
Enrollment	202 participants
Start Date	2024-01-01
Primary Completion	2025-04-30 (estimated)
Study Completion	2025-08-15 (estimated)
Updated on ClinicalTrials.gov	2026-02-05